Thus, the previously described transient increase in the frequencies of TAA-specific CD8+ T cells after therapy-induced local tumor destruction [7, 23, 30] was probably missed in our HLA-A2- and HLA-A3 restricted cohort. Here, CD8A is linked to neoplasm.